|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Tumors | |||||
| 2 | Interventions listed in this trial | ||||
| dasatinib | |||||
| 3 | More general drug interventions related to this trial | ||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Protein Kinase Inhibitors | |||||
| 4 | Sponsors listed in this trial | ||||
| Bristol-Myers Squibb | |||||